Our results showed that Tau expression was significantly higher in the ER- and PR-positive groups (p

Our results showed that Tau expression was significantly higher in the ER- and PR-positive groups (p<.001 and p<.001, respectively), supporting the relationship with Tau and hormone-related factors. and loss of -tubulin and III-tubulin expression were correlated with aggressive behavior in taxane-treated breast cancer. Further evaluation of Tau, -tubulin and III-tubulin may be useful in predicting clinical behavior and seeking therapeutic measures in taxane-based chemotherapy for breast cancer. Keywords:Tau proteins, Tubulin, Taxoids, Breast neoplasms Breast cancer is one of the most common malignancies and is the leading cause of cancer death among women.1The heterogeneous nature of its histology, phenotype and clinical behavior leads to the need for targeted therapeutic agents. Tau, a microtubule-associated protein (MAP), binds to both the inner and outer surfaces of microtubules, leading to tubulin assembly and microtubule stabilization.2Tubulin heterodimers consist of - and -tubulins, and the -subunit binds taxane and causes suppression of both microtubular dynamics and cell proliferation.3Overexpression of III-tubulin has been demonstrated in a variety of malignancies, including non-small-cell lung cancer and ovarian, gastric, prostate and breast cancers.4Previous studies have implicated Tau and tubulin expression in breast cancer.5-11The purpose of this study was to evaluate the expression of the MAP Tau, -tubulin, and III-tubulin in breast cancer and correlate their expressions with known clinicopathologic parameters, disease progression and overall survival of patients. Furthermore, the relationships among Tau, -tubulin, and III-tubulin expression and disease progression and overall survival of the patients were also evaluated in the context of taxane use as adjuvant chemotherapy. == MATERIALS AND METHODS == == Clinical samples == A total of 183 primary breast carcinoma patients PRDI-BF1 who had undergone surgical resection at St. Vincent’s Hospital (Suwon, Korea) between January 1999 and August 2007 and had available follow-up data were included in this study. Neither chemotherapy nor radiotherapy was performed before surgery. Formalin-fixed paraffin-embedded (FFPE) tissue and medical data were collected for each patient. All the archival hematoxylin and eosin (H&E)-stained slides for each patient were examined. The nuclear marks and histologic marks were evaluated according to the Nottingham grading system.12The tumor stages were evaluated according to the criteria of the 7th edition of the American Joint Committee PROTAC FAK degrader 1 on Cancer (AJCC). Medical records were collected and examined retrospectively. Disease progression was defined as local recurrence, distant metastasis or disease-related death. This study was authorized by the Institutional Review Table of The Catholic University or PROTAC FAK degrader 1 college of Korea (VC12SISI0158). == Cells microarray == Cells microarrays (TMAs) were constructed from FFPE cells blocks of 183 invasive carcinomas. The representative tumor site was chosen on H&E slides, and the site corresponding to the confirmed tumor site in the paraffin block was noticeable. PROTAC FAK degrader 1 Areas with necrosis, hemorrhage and artifacts were excluded. One selected area per each case was harvested using a 2-mm Quick-Ray tip-punch (Micro Digital Co., Seoul, Korea) and was transferred to a TMA mold with 60 pores and re-embedded with paraffin. TMA blocks PROTAC FAK degrader 1 were prepared as 4-m-thick sections and were stained with H&E staining methods. The tissues were then examined to determine whether the appropriate tumor site had been selected. == Immunohistochemistry == Immunohistochemical staining was carried out on 4-m sections of the TMA blocks. The paraffin sections were mounted on poly-L-lysine-coated glass slides, deparaffinized, and rehydrated inside a graded series of ethanol, followed by antigen retrieval using a microwave. Endogenous peroxidase activity was clogged by treating the slides with 3% H2O2in methanol for 10 minutes at space temperature. The primary antibodies were incubated over night at 4. The following main antibodies were used: Tau (1:200, #RB-1239-R7, Lab Vision, Fremont, CA, USA), -tubulin (1:200, #RB-9281-R7, Lab Vision), III-tubulin (1:800, MU177-UC, BioGenex, San Ramon, CA, USA), estrogen receptor (ER; 1:300, 6F11, Novocastra, Newcastle upon Tyne, UK), progesterone receptor (PR; 1:600, 16, Novocastra), and HER2 (1:1,800, polyclonal, Dako, Glostrup, Denmark). Immunostaining was carried out.